ACSL4 promotes prostate cancer growth, invasion and hormonal resistance

作者：Wu Xinyu; Deng Fangming; Li Yirong; Daniels Garrett; Du Xinxin; Ren Qinghu; Wang Jinhua; Wang Ling Hang; Yang Yang; Zhang Valerio; Zhang David; Ye Fei; Melamed Jonathan; Monaco Marie E^*; Lee Peng

来源：Oncotarget, 2015, 6(42): 44849-44863.

DOI：10.18632/oncotarget.6438

• androgen receptor
• prostate cancer
• ACSL4
• castration resistance

Increases in fatty acid metabolism have been demonstrated to promote the growth and survival of a variety of cancers, including prostate cancer (PCa). Here, we examine the expression and function of the fatty acid activating enzyme, long-chain fatty acyl-CoA synthetase 4 (ACSL4), in PCa. Ectopic expression of ACSL4 in ACSL4-negative PCa cells increases proliferation, migration and invasion, while ablation of ACSL4 in PCa cells expressing endogenous ACSL4 reduces cell proliferation, migration and invasion. The cell proliferative effects were observed both in vitro, as well as in vivo. Immunohistochemical analysis of human PCa tissue samples indicated ACSL4 expression is increased in malignant cells compared with adjacent benign epithelial cells, and particularly increased in castration-resistant PCa (CRPC) when compared with hormone naive PCa. In cell lines co-expressing both ACSL4 and AR, proliferation was independent of exogenous androgens, suggesting that ACSL4 expression may lead to CRPC. In support for this hypothesis, ectopic ACSL4 expression induced resistance to treatment with Casodex, via decrease in apoptosis. Our studies further indicate that ACSL4 upregulates distinct pathway proteins including p-AKT, LSD1 and beta-catenin. These results suggest ACSL4 could serve as a biomarker and potential therapeutic target for CRPC.

• 出版日期2015-12-29